ASNC2026 to Showcase Pivotal Phase 3 Trials Advancing Cardiac Amyloidosis Diagnosis and Treatment
FAIRFAX, VA, UNITED STATES, August 27, 2026 /EINPresswire.com/ -- New Phase 3 clinical trial findings spanning the diagnosis, imaging, and treatment of cardiac amyloidosis will be presented at the American Society of Nuclear Cardiology 31st Annual …